ERIN SMITH: Open Payments
NPI 1639614431 · MOREHEAD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 43 payments from 10 companies in 2025. Trend: 2023 $874 · 2024 $817 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $243 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Novo Nordisk Inc | 4 | $90 |
| PFIZER INC. | 5 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| AtriCure, Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, ELIQUIS, BRILINTA, Wegovy, LifeVest, VERQUVO, ATRICLIP LAA EXCLUSION SYSTEM, FARXIGA.
Industry payments across KY — which companies pay providers there.
